Among AD blood-based biomarkers, the strong association of GFAP and pTau-181 with the diagnosis of AD replicated previous findings.22,23 Although promising, these results should be interpreted with caution since they were obtained from a small observational study and their replication in an independent, larger cohort is warranted. Here, GFAP is linked to Alzheimer disease.